| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.02e-09 | 16 | 163 | 6 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 NOL3 DLL4 FAT3 GAS6 DLK1 PKD1L2 ADGRE2 VWCE LDLR STAB1 JAG2 EYS NRXN1 ASPH LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 PADI3 | 2.13e-09 | 749 | 163 | 25 | GO:0005509 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.32e-08 | 21 | 163 | 6 | GO:0030228 | |
| GeneOntologyMolecularFunction | Notch binding | 2.38e-06 | 27 | 163 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 5.28e-06 | 5 | 163 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.20e-05 | 18 | 163 | 4 | GO:0030169 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 6.93e-05 | 85 | 163 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.44e-04 | 13 | 163 | 3 | GO:0046975 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 1.84e-04 | 35 | 163 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 1.84e-04 | 35 | 163 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 ERBB4 HTR2C GRM2 ADGRE2 CR1 LEPR GFRA1 GFRA3 IGF1R NRXN3 CSF3R NRXN1 NRXN2 OR52H1 UNC5C LRP5 IL17RA ADGRE1 LTBP4 ALK NOTCH1 NOTCH2 SORL1 | 2.64e-04 | 1353 | 163 | 24 | GO:0004888 |
| GeneOntologyMolecularFunction | histone H3K36 dimethyltransferase activity | 3.93e-04 | 4 | 163 | 2 | GO:0140954 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity involved in amyloid precursor protein catabolic process | 3.93e-04 | 4 | 163 | 2 | GO:1902945 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 4.50e-04 | 44 | 163 | 4 | GO:0140938 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 4.58e-04 | 120 | 163 | 6 | GO:0004222 | |
| GeneOntologyMolecularFunction | glial cell-derived neurotrophic factor receptor activity | 6.52e-04 | 5 | 163 | 2 | GO:0016167 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 6.52e-04 | 5 | 163 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 9.72e-04 | 6 | 163 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 9.85e-04 | 54 | 163 | 4 | GO:0005246 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.20e-03 | 97 | 163 | 5 | GO:0004896 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.35e-03 | 27 | 163 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | cytokine binding | 1.85e-03 | 157 | 163 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.17e-03 | 162 | 163 | 6 | GO:0099106 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 2.32e-03 | 68 | 163 | 4 | GO:0016279 | |
| GeneOntologyMolecularFunction | immune receptor activity | 2.37e-03 | 165 | 163 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 2.45e-03 | 69 | 163 | 4 | GO:0016278 | |
| GeneOntologyBiologicalProcess | axon guidance | LAMC2 GDNF GFRA3 NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 4.22e-07 | 285 | 162 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | LAMC2 GDNF GFRA3 NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 4.39e-07 | 286 | 162 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | cardiac atrium development | 8.88e-07 | 42 | 162 | 6 | GO:0003230 | |
| GeneOntologyBiologicalProcess | tissue remodeling | NOL3 DLL4 DLK1 LEPR PLEKHM1 WNT16 CST5 LRP1 LRP5 LTBP3 TNFAIP3 NOTCH2 | 1.14e-06 | 262 | 162 | 12 | GO:0048771 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 LDLR LEPR STAB1 SETD2 NRXN3 NRXN1 LRP1 LRP2 LRP5 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 1.80e-06 | 817 | 162 | 21 | GO:0048514 |
| GeneOntologyBiologicalProcess | circulatory system development | SP2 ERBB4 STAB2 ADAM19 THSD7A ANK2 ADAMTS1 DLL4 NSD2 CAMP ADAM12 LDLR LEPR STAB1 SETD2 IGF1R NRXN3 NRXN1 WNT16 LRP1 LRP2 LRP5 AKAP13 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 2.51e-06 | 1442 | 162 | 29 | GO:0072359 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | STAB2 SPEM3 THSD7A ANK2 ADAMTS1 DLL4 FAT3 CAMP ADAM12 GDNF LEPR STAB1 SETD2 NRXN3 CSF3R NRXN1 FIG4 WNT16 ERVK-8 LRP2 AKAP13 ADAM17 TNFAIP3 CCNB1IP1 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 4.34e-06 | 1483 | 162 | 29 | GO:0048646 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 4.70e-06 | 5 | 162 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 4.70e-06 | 5 | 162 | 3 | GO:0061642 | |
| GeneOntologyBiologicalProcess | bone remodeling | 7.40e-06 | 127 | 162 | 8 | GO:0046849 | |
| GeneOntologyBiologicalProcess | blood vessel development | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 LDLR LEPR STAB1 SETD2 NRXN3 NRXN1 LRP1 LRP2 LRP5 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 1.30e-05 | 929 | 162 | 21 | GO:0001568 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.63e-05 | 7 | 162 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 GDNF LDLR LEPR STAB1 ADAMTS12 SETD2 NRXN3 NRXN1 LRP1 LRP2 LRP5 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 2.43e-05 | 1125 | 162 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | vasculature development | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 LDLR LEPR STAB1 SETD2 NRXN3 NRXN1 LRP1 LRP2 LRP5 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 2.43e-05 | 969 | 162 | 21 | GO:0001944 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | WASL FAT3 LAMC2 BCL11A TECTA GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 2.51e-05 | 748 | 162 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | adult behavior | 3.35e-05 | 203 | 162 | 9 | GO:0030534 | |
| GeneOntologyBiologicalProcess | axonogenesis | LAMC2 BCL11A GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 4.18e-05 | 566 | 162 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 4.36e-05 | 210 | 162 | 9 | GO:0007219 | |
| GeneOntologyBiologicalProcess | angiogenesis | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 LEPR STAB1 SETD2 NRXN3 NRXN1 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 4.38e-05 | 708 | 162 | 17 | GO:0001525 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.70e-05 | 212 | 162 | 9 | GO:0003205 | |
| GeneOntologyBiologicalProcess | neuron projection development | WASL ADAMTS1 FAT3 LAMC2 BCL11A ITGA1 TECTA GDNF GFRA1 GFRA3 IGF1R NRXN3 NRXN1 TENM3 SEMA5B FIG4 UNC5C LRP1 LRP2 ADAM17 ALK NOTCH1 NOTCH2 NOTCH3 | 6.73e-05 | 1285 | 162 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 6.91e-05 | 128 | 162 | 7 | GO:0034103 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 8.74e-05 | 92 | 162 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | tube development | STAB2 THSD7A ADAMTS1 DLL4 CAMP ADAM12 GDNF LDLR LEPR STAB1 ADAMTS12 SETD2 GJB1 NRXN3 NRXN1 LRP1 LRP2 LRP5 LTBP3 TNFAIP3 RECK NOTCH1 NOTCH2 NOTCH3 SPINK5 | 9.80e-05 | 1402 | 162 | 25 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 9.93e-05 | 12 | 162 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ERBB4 ADAMTS1 DLL4 NSD2 FAT3 LAMC2 TECTA GDNF RING1 JAG2 SETD2 IGF1R CSF3R TENM3 WNT16 CST5 LRP2 LRP5 LTBP3 PAX4 TNFAIP3 NOTCH1 NOTCH2 | 1.51e-04 | 1269 | 162 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 1.59e-04 | 35 | 162 | 4 | GO:0003209 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.60e-04 | 249 | 162 | 9 | GO:0010976 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.62e-04 | 14 | 162 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | axon development | LAMC2 BCL11A GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 1.69e-04 | 642 | 162 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 1.83e-04 | 3 | 162 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | WASL LAMC2 BCL11A ITGA1 GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 1.98e-04 | 802 | 162 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | glial cell-derived neurotrophic factor receptor signaling pathway | 2.02e-04 | 15 | 162 | 3 | GO:0035860 | |
| GeneOntologyBiologicalProcess | chemotaxis | WASL GAS6 ITGA1 ADGRE2 GDNF CSF3R SEMA5B UNC5C LRP1 LRP2 ADAM17 IL17RA NOTCH1 | 2.30e-04 | 517 | 162 | 13 | GO:0006935 |
| GeneOntologyBiologicalProcess | taxis | WASL GAS6 ITGA1 ADGRE2 GDNF CSF3R SEMA5B UNC5C LRP1 LRP2 ADAM17 IL17RA NOTCH1 | 2.39e-04 | 519 | 162 | 13 | GO:0042330 |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 2.47e-04 | 16 | 162 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | WASL LAMC2 BCL11A ITGA1 GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 2.53e-04 | 819 | 162 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | negative regulation of peptidase activity | 2.61e-04 | 210 | 162 | 8 | GO:0010466 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 2.69e-04 | 40 | 162 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | WASL LAMC2 BCL11A ITGA1 GDNF GFRA3 IGF1R NRXN3 NRXN1 SEMA5B UNC5C LRP1 LRP2 ADAM17 NOTCH1 NOTCH2 NOTCH3 | 2.79e-04 | 826 | 162 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 3.64e-04 | 4 | 162 | 2 | GO:0070433 | |
| GeneOntologyBiologicalProcess | negative regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 3.64e-04 | 4 | 162 | 2 | GO:0070425 | |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 3.64e-04 | 4 | 162 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | NOL3 GAS6 GRM2 CR1 LEPR CST5 LRP1 LRP5 TNFAIP3 SMCR8 WFDC12 RECK NOTCH1 SPINK5 | 3.64e-04 | 615 | 162 | 14 | GO:0043086 |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | ERBB4 DLL4 GAS6 GDNF GFRA1 ADAMTS12 IGF1R NRXN1 LRP1 SCUBE3 LRP2 ADAM17 LTBP3 LTBP4 NOTCH1 NOTCH2 SORL1 | 3.88e-04 | 850 | 162 | 17 | GO:0071363 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 4.13e-04 | 171 | 162 | 7 | GO:0048593 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 4.20e-04 | 80 | 162 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 4.20e-04 | 80 | 162 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular component organization | WASL NOL3 EML4 FAT3 BCL11A PRRT2 LDLR NRXN1 DNAJA4 CST5 LRP1 TNKS ADAM17 CKAP2 SMCR8 NOTCH1 SORL1 | 4.67e-04 | 864 | 162 | 17 | GO:0051129 |
| GeneOntologyBiologicalProcess | neuron development | WASL ADAMTS1 FAT3 LAMC2 BCL11A ITGA1 TECTA GDNF GFRA1 GFRA3 IGF1R NRXN3 NRXN1 TENM3 SEMA5B FIG4 UNC5C LRP1 LRP2 ADAM17 ALK NOTCH1 NOTCH2 NOTCH3 | 4.70e-04 | 1463 | 162 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | DLL4 MBNL1 NSD1 TECTA GDNF JAG2 SETD2 TRIM28 WNT16 LRP2 LRP5 TNFAIP3 RECK NOTCH1 NOTCH2 | 5.14e-04 | 713 | 162 | 15 | GO:0048598 |
| GeneOntologyBiologicalProcess | response to growth factor | ERBB4 DLL4 GAS6 GDNF GFRA1 ADAMTS12 IGF1R NRXN1 LRP1 SCUBE3 LRP2 ADAM17 LTBP3 LTBP4 NOTCH1 NOTCH2 SORL1 | 5.97e-04 | 883 | 162 | 17 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of hydrolase activity | 5.98e-04 | 298 | 162 | 9 | GO:0051346 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 6.04e-04 | 5 | 162 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 6.35e-04 | 240 | 162 | 8 | GO:0070374 | |
| GeneOntologyBiologicalProcess | artery development | 6.45e-04 | 133 | 162 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | signal release | HTR2C PRRT2 GRM2 GDNF LEPR NRXN3 NRXN1 NRXN2 SYTL4 LRP1 SYP LRP5 ADAM17 LTBP4 | 6.59e-04 | 653 | 162 | 14 | GO:0023061 |
| GeneOntologyBiologicalProcess | cardiac septum development | 6.71e-04 | 134 | 162 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | secretion by cell | HTR2C PRRT2 GRM2 ADGRE2 GDNF LEPR NRXN3 MALRD1 NRXN1 NRXN2 SYTL4 LRP1 SYP LRP5 ADAM17 OLFM2 SMCR8 LTBP4 NOTCH1 | 7.07e-04 | 1064 | 162 | 19 | GO:0032940 |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 7.96e-04 | 53 | 162 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | ERBB4 GAS6 LEPR GPD1L MALRD1 NRXN1 SYTL4 TRIM28 ASPH LRP1 LRP2 LRP5 SORL1 | 8.12e-04 | 591 | 162 | 13 | GO:1903829 |
| GeneOntologyBiologicalProcess | endocytosis | NPC1 WASL STAB2 ANK2 GAS6 LDLR LEPR STAB1 MTMR6 ARFGAP3 LRP1 LRP2 LRP3 SYP LRP5 SORL1 | 8.24e-04 | 827 | 162 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | vocalization behavior | 8.53e-04 | 24 | 162 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 8.53e-04 | 24 | 162 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 8.53e-04 | 24 | 162 | 3 | GO:0045056 | |
| GeneOntologyBiologicalProcess | membrane organization | NPC1 WASL SPIRE2 ANK2 NOL3 GAS6 ZNF205 PRRT2 CR1 GDNF PLEKHM1 NRXN1 NRXN2 SYTL4 ARFGAP3 SYP LRP5 | 8.75e-04 | 914 | 162 | 17 | GO:0061024 |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 9.01e-04 | 6 | 162 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 9.01e-04 | 6 | 162 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 9.01e-04 | 6 | 162 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 9.01e-04 | 6 | 162 | 2 | GO:0009912 | |
| GeneOntologyCellularComponent | receptor complex | TRAF1 ERBB4 HTR2C ITGA1 CR1 GDNF LDLR LEPR GFRA1 GFRA3 AHRR IGF1R CSF3R LRP1 LRP2 LRP5 OLFM2 ALK NOTCH1 NOTCH2 NOTCH3 | 7.55e-09 | 581 | 166 | 21 | GO:0043235 |
| GeneOntologyCellularComponent | external side of plasma membrane | STAB2 ADAM19 HTR2C ADAM29 DLK1 ITGA1 ADGRE2 CR1 LDLR LEPR GFRA1 GFRA3 CSF3R LRP1 LRP2 ADGRE1 | 4.06e-06 | 519 | 166 | 16 | GO:0009897 |
| GeneOntologyCellularComponent | cell surface | STAB2 ADAM19 HTR2C ADAM29 DLK1 ITGA1 ADGRE2 CR1 LDLR LEPR GFRA1 GFRA3 CSF3R NRXN1 UNC5C LRP1 SCUBE3 LRP2 ADAM17 ADGRE1 NOTCH1 NOTCH2 NOTCH3 SORL1 | 7.78e-06 | 1111 | 166 | 24 | GO:0009986 |
| GeneOntologyCellularComponent | side of membrane | TRAF1 STAB2 ADAM19 HTR2C ANK2 ADAM29 DLK1 ITGA1 TECTA ADGRE2 CR1 LDLR LEPR GFRA1 GFRA3 CSF3R LRP1 LRP2 ADGRE1 RECK | 2.15e-05 | 875 | 166 | 20 | GO:0098552 |
| Domain | EGF-like_dom | STAB2 ADAM19 DLL4 FAT3 GAS6 LAMC2 ADAM29 DLK1 TECTA ADGRE2 VWCE ADAM12 LDLR STAB1 JAG2 EYS NRXN3 FCGBP MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 LTBP3 C7 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 9.27e-33 | 249 | 159 | 35 | IPR000742 |
| Domain | EGF-like_CS | STAB2 ADAM19 DLL4 FAT3 GAS6 LAMC2 ADAM29 DLK1 ZNRF4 ADGRE2 VWCE ADAM12 LDLR STAB1 JAG2 EYS NRXN3 MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 ADAM17 LTBP3 C7 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 5.02e-32 | 261 | 159 | 35 | IPR013032 |
| Domain | EGF_3 | STAB2 ADAM19 DLL4 FAT3 GAS6 ADAM29 DLK1 ADGRE2 VWCE ADAM12 LDLR STAB1 JAG2 EYS NRXN3 MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 LTBP3 C7 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.68e-29 | 235 | 159 | 32 | PS50026 |
| Domain | EGF_2 | STAB2 ADAM19 DLL4 FAT3 GAS6 LAMC2 ADAM29 DLK1 ADGRE2 VWCE ADAM12 LDLR STAB1 JAG2 EYS NRXN3 MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 LTBP3 C7 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 4.09e-29 | 265 | 159 | 33 | PS01186 |
| Domain | EGF_1 | STAB2 ADAM19 DLL4 FAT3 GAS6 LAMC2 ADAM29 DLK1 ADGRE2 VWCE ADAM12 LDLR STAB1 JAG2 EYS NRXN3 MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 LTBP3 C7 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 2.41e-28 | 255 | 159 | 32 | PS00022 |
| Domain | EGF | STAB2 DLL4 FAT3 GAS6 LAMC2 DLK1 TECTA ADGRE2 VWCE LDLR STAB1 JAG2 EYS NRXN3 FCGBP MALRD1 NRXN1 TENM3 NRXN2 ATRNL1 LRP1 SCUBE3 LRP2 LRP5 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 3.79e-28 | 235 | 159 | 31 | SM00181 |
| Domain | ASX_HYDROXYL | DLL4 FAT3 GAS6 DLK1 ADGRE2 VWCE LDLR JAG2 EYS NRXN3 NRXN1 LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 3.52e-22 | 100 | 159 | 20 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | DLL4 FAT3 GAS6 DLK1 ADGRE2 VWCE LDLR JAG2 EYS NRXN3 NRXN1 LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 1.22e-21 | 106 | 159 | 20 | IPR000152 |
| Domain | EGF-like_Ca-bd_dom | STAB2 DLL4 FAT3 GAS6 DLK1 ADGRE2 VWCE LDLR STAB1 JAG2 EYS LRP1 SCUBE3 LRP2 LRP5 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 1.24e-21 | 124 | 159 | 21 | IPR001881 |
| Domain | EGF_CA | STAB2 DLL4 FAT3 GAS6 DLK1 ADGRE2 VWCE LDLR STAB1 JAG2 EYS LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 2.37e-20 | 122 | 159 | 20 | SM00179 |
| Domain | Growth_fac_rcpt_ | ERBB4 STAB2 DLL4 GAS6 LAMC2 ADGRE2 VWCE LDLR STAB1 JAG2 EYS IGF1R LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 1.80e-19 | 156 | 159 | 21 | IPR009030 |
| Domain | EGF | STAB2 DLL4 GAS6 DLK1 TECTA STAB1 JAG2 EYS NRXN3 MALRD1 NRXN1 NRXN2 LRP1 SCUBE3 LRP2 LRP5 NOTCH1 NOTCH2 NOTCH3 | 1.14e-18 | 126 | 159 | 19 | PF00008 |
| Domain | EGF_CA | FAT3 GAS6 ADGRE2 VWCE LDLR JAG2 EYS LRP1 SCUBE3 LRP2 LRP5 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 8.21e-18 | 99 | 159 | 17 | PS01187 |
| Domain | EGF_Ca-bd_CS | FAT3 GAS6 ADGRE2 VWCE LDLR JAG2 EYS LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 1.55e-16 | 97 | 159 | 16 | IPR018097 |
| Domain | EGF_CA | FAT3 GAS6 ADGRE2 VWCE LDLR JAG2 LRP1 SCUBE3 LRP2 LTBP3 ADGRE1 LTBP4 NOTCH1 NOTCH2 NOTCH3 | 5.92e-16 | 86 | 159 | 15 | PF07645 |
| Domain | EGF_extracell | STAB2 ADAM19 DLL4 DLK1 ADAM12 STAB1 JAG2 TENM3 ATRNL1 LRP2 NOTCH1 NOTCH3 | 9.37e-14 | 60 | 159 | 12 | IPR013111 |
| Domain | EGF_2 | STAB2 ADAM19 DLL4 DLK1 ADAM12 STAB1 JAG2 TENM3 ATRNL1 LRP2 NOTCH1 NOTCH3 | 9.37e-14 | 60 | 159 | 12 | PF07974 |
| Domain | - | 4.71e-12 | 46 | 159 | 10 | 4.10.400.10 | |
| Domain | LDLRA_1 | 7.45e-12 | 48 | 159 | 10 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 9.29e-12 | 49 | 159 | 10 | IPR002172 | |
| Domain | LDLa | 9.29e-12 | 49 | 159 | 10 | SM00192 | |
| Domain | LDLRA_2 | 9.29e-12 | 49 | 159 | 10 | PS50068 | |
| Domain | LDLR_class-A_CS | 4.08e-11 | 40 | 159 | 9 | IPR023415 | |
| Domain | Ldl_recept_a | 1.28e-10 | 45 | 159 | 9 | PF00057 | |
| Domain | hEGF | 2.89e-09 | 28 | 159 | 7 | PF12661 | |
| Domain | cEGF | 6.93e-08 | 26 | 159 | 6 | PF12662 | |
| Domain | cEGF | 6.93e-08 | 26 | 159 | 6 | IPR026823 | |
| Domain | Ldl_recept_b | 7.90e-08 | 14 | 159 | 5 | PF00058 | |
| Domain | LDLRB | 7.90e-08 | 14 | 159 | 5 | PS51120 | |
| Domain | LY | 1.18e-07 | 15 | 159 | 5 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.18e-07 | 15 | 159 | 5 | IPR000033 | |
| Domain | VWC_out | 4.43e-07 | 19 | 159 | 5 | SM00215 | |
| Domain | DUF3454 | 6.05e-07 | 3 | 159 | 3 | PF11936 | |
| Domain | DUF3454_notch | 6.05e-07 | 3 | 159 | 3 | IPR024600 | |
| Domain | DUF3454 | 6.05e-07 | 3 | 159 | 3 | SM01334 | |
| Domain | LAM_G_DOMAIN | 7.63e-07 | 38 | 159 | 6 | PS50025 | |
| Domain | Pep_M12B_propep | 8.96e-07 | 39 | 159 | 6 | PF01562 | |
| Domain | Peptidase_M12B_N | 8.96e-07 | 39 | 159 | 6 | IPR002870 | |
| Domain | - | 8.96e-07 | 39 | 159 | 6 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 1.05e-06 | 40 | 159 | 6 | PS00427 | |
| Domain | Reprolysin | 1.05e-06 | 40 | 159 | 6 | PF01421 | |
| Domain | Laminin_G_2 | 1.05e-06 | 40 | 159 | 6 | PF02210 | |
| Domain | ADAM_MEPRO | 1.05e-06 | 40 | 159 | 6 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.05e-06 | 40 | 159 | 6 | PS50214 | |
| Domain | Peptidase_M12B | 1.05e-06 | 40 | 159 | 6 | IPR001590 | |
| Domain | Disintegrin_dom | 1.22e-06 | 41 | 159 | 6 | IPR001762 | |
| Domain | LamG | 1.87e-06 | 44 | 159 | 6 | SM00282 | |
| Domain | Notch | 2.41e-06 | 4 | 159 | 3 | IPR008297 | |
| Domain | NODP | 2.41e-06 | 4 | 159 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 2.41e-06 | 4 | 159 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.41e-06 | 4 | 159 | 3 | IPR010660 | |
| Domain | NOD | 2.41e-06 | 4 | 159 | 3 | PF06816 | |
| Domain | NOD | 2.41e-06 | 4 | 159 | 3 | SM01338 | |
| Domain | NODP | 2.41e-06 | 4 | 159 | 3 | SM01339 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.45e-06 | 46 | 159 | 6 | IPR011042 | |
| Domain | TIL_dom | 4.74e-06 | 14 | 159 | 4 | IPR002919 | |
| Domain | AWS | 5.98e-06 | 5 | 159 | 3 | SM00570 | |
| Domain | AWS | 5.98e-06 | 5 | 159 | 3 | PS51215 | |
| Domain | AWS_dom | 5.98e-06 | 5 | 159 | 3 | IPR006560 | |
| Domain | LNR | 5.98e-06 | 5 | 159 | 3 | PS50258 | |
| Domain | Laminin_G | 9.72e-06 | 58 | 159 | 6 | IPR001791 | |
| Domain | TSP_1 | 1.58e-05 | 63 | 159 | 6 | PF00090 | |
| Domain | VWC | 1.68e-05 | 38 | 159 | 5 | SM00214 | |
| Domain | TSP1 | 1.89e-05 | 65 | 159 | 6 | SM00209 | |
| Domain | TSP1_rpt | 1.89e-05 | 65 | 159 | 6 | IPR000884 | |
| Domain | TSP1 | 1.89e-05 | 65 | 159 | 6 | PS50092 | |
| Domain | Notch_dom | 2.07e-05 | 7 | 159 | 3 | IPR000800 | |
| Domain | Syndecan | 2.07e-05 | 7 | 159 | 3 | PF01034 | |
| Domain | Notch | 2.07e-05 | 7 | 159 | 3 | PF00066 | |
| Domain | Syndecan/Neurexin_dom | 2.07e-05 | 7 | 159 | 3 | IPR027789 | |
| Domain | NL | 2.07e-05 | 7 | 159 | 3 | SM00004 | |
| Domain | - | 2.20e-05 | 20 | 159 | 4 | 4.10.70.10 | |
| Domain | Disintegrin | 2.70e-05 | 21 | 159 | 4 | PF00200 | |
| Domain | DISIN | 2.70e-05 | 21 | 159 | 4 | SM00050 | |
| Domain | VWF_dom | 2.77e-05 | 42 | 159 | 5 | IPR001007 | |
| Domain | - | 6.64e-05 | 81 | 159 | 6 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 6.64e-05 | 81 | 159 | 6 | IPR024079 | |
| Domain | ADAM_Cys-rich | 7.62e-05 | 27 | 159 | 4 | IPR006586 | |
| Domain | ACR | 7.62e-05 | 27 | 159 | 4 | SM00608 | |
| Domain | EGF_LAM_2 | 1.17e-04 | 30 | 159 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.17e-04 | 30 | 159 | 4 | PS01248 | |
| Domain | EGF_dom | 1.26e-04 | 12 | 159 | 3 | IPR024731 | |
| Domain | C8 | 1.26e-04 | 12 | 159 | 3 | PF08742 | |
| Domain | EGF_3 | 1.26e-04 | 12 | 159 | 3 | PF12947 | |
| Domain | TIL | 1.26e-04 | 12 | 159 | 3 | PF01826 | |
| Domain | - | 1.61e-04 | 95 | 159 | 6 | 2.60.120.200 | |
| Domain | Unchr_dom_Cys-rich | 1.63e-04 | 13 | 159 | 3 | IPR014853 | |
| Domain | C8 | 1.63e-04 | 13 | 159 | 3 | SM00832 | |
| Domain | ZINC_PROTEASE | 1.91e-04 | 98 | 159 | 6 | PS00142 | |
| Domain | Neurexin-like | 2.06e-04 | 14 | 159 | 3 | IPR003585 | |
| Domain | 4.1m | 2.06e-04 | 14 | 159 | 3 | SM00294 | |
| Domain | TILa_dom | 2.15e-04 | 3 | 159 | 2 | IPR025615 | |
| Domain | TILa | 2.15e-04 | 3 | 159 | 2 | PF12714 | |
| Domain | EGF_Lam | 2.16e-04 | 35 | 159 | 4 | SM00180 | |
| Domain | VWFC_2 | 2.98e-04 | 38 | 159 | 4 | PS50184 | |
| Domain | Laminin_EGF | 2.98e-04 | 38 | 159 | 4 | IPR002049 | |
| Domain | Post-SET_dom | 3.13e-04 | 16 | 159 | 3 | IPR003616 | |
| Domain | PostSET | 3.13e-04 | 16 | 159 | 3 | SM00508 | |
| Domain | VWF_type-D | 3.13e-04 | 16 | 159 | 3 | IPR001846 | |
| Domain | VWFD | 3.13e-04 | 16 | 159 | 3 | PS51233 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.01e-08 | 13 | 120 | 5 | M47423 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 8.58e-08 | 27 | 120 | 6 | M39545 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 9.43e-08 | 45 | 120 | 7 | M39571 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.05e-07 | 68 | 120 | 8 | M27303 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.10e-07 | 46 | 120 | 7 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.29e-07 | 47 | 120 | 7 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.71e-07 | 7 | 120 | 4 | M27199 | |
| Pathway | PID_NOTCH_PATHWAY | 6.42e-07 | 59 | 120 | 7 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 8.10e-07 | 61 | 120 | 7 | M39540 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.57e-06 | 11 | 120 | 4 | M47865 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 5.85e-06 | 31 | 120 | 5 | M592 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 5.94e-06 | 5 | 120 | 3 | M27411 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.09e-06 | 82 | 120 | 7 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 6.34e-06 | 15 | 120 | 4 | M27202 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.09e-05 | 17 | 120 | 4 | M39389 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.18e-05 | 6 | 120 | 3 | M27068 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.98e-05 | 143 | 120 | 8 | M27275 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 4.65e-05 | 24 | 120 | 4 | M11190 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.05e-05 | 154 | 120 | 8 | M39739 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 6.56e-05 | 118 | 120 | 7 | M39852 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.92e-05 | 161 | 120 | 8 | M39770 | |
| Pathway | REACTOME_ALK_MUTANTS_BIND_TKIS | 1.25e-04 | 12 | 120 | 3 | M42522 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.25e-04 | 12 | 120 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.25e-04 | 12 | 120 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.62e-04 | 13 | 120 | 3 | M47534 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.76e-04 | 97 | 120 | 6 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.20e-04 | 101 | 120 | 6 | M39448 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM19 ADAMTS1 LAMC2 ITGA1 ADAM12 NRXN1 SCUBE3 ADAM17 LTBP3 LTBP4 | 2.42e-04 | 300 | 120 | 10 | M610 |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.11e-04 | 16 | 120 | 3 | M47424 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.26e-04 | 39 | 120 | 4 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.26e-04 | 39 | 120 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 3.26e-04 | 39 | 120 | 4 | MM15165 | |
| Pathway | WP_CANCER_PATHWAYS | TRAF1 DLL4 EML4 LAMC2 JAG2 IGF1R CSF3R WNT16 LRP5 ALK NOTCH1 NOTCH2 NOTCH3 | 3.77e-04 | 507 | 120 | 13 | M48302 |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 4.05e-04 | 381 | 120 | 11 | M48063 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.14e-04 | 74 | 120 | 5 | M616 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.47e-04 | 18 | 120 | 3 | M614 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 5.21e-04 | 44 | 120 | 4 | M13720 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.28e-04 | 19 | 120 | 3 | MM15594 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 6.18e-04 | 46 | 120 | 4 | MM14933 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 7.07e-04 | 5 | 120 | 2 | MM14733 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 7.87e-04 | 49 | 120 | 4 | M618 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 8.23e-04 | 22 | 120 | 3 | M27210 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 1.05e-03 | 6 | 120 | 2 | MM1584 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 1.05e-03 | 6 | 120 | 2 | M22074 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.21e-03 | 25 | 120 | 3 | M27879 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.33e-03 | 250 | 120 | 8 | M27554 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 1.47e-03 | 7 | 120 | 2 | MM1563 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 1.47e-03 | 7 | 120 | 2 | M22043 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.47e-03 | 7 | 120 | 2 | MM14734 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.49e-03 | 58 | 120 | 4 | M29616 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 1.52e-03 | 27 | 120 | 3 | M45550 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.69e-03 | 28 | 120 | 3 | M6177 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.95e-03 | 8 | 120 | 2 | M47850 | |
| Pubmed | THSD7A ZNF318 ZNF77 RESF1 NRXN1 ATRNL1 LRP1 LRP2 LTBP3 MUC5AC SPINK5 | 4.78e-14 | 71 | 168 | 11 | 33541421 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | ERBB4 CR1 LDLR LEPR IGF1R LRP1 LRP2 ALK NOTCH1 NOTCH2 NOTCH3 | 2.62e-12 | 101 | 168 | 11 | 23382219 |
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.38e-10 | 17 | 168 | 6 | 15821257 | |
| Pubmed | 3.07e-10 | 9 | 168 | 5 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 6.12e-10 | 10 | 168 | 5 | 23665443 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NPC1 SPIRE2 NSD2 GRK6 NSD1 LDLR PLEKHM1 DHX30 JAG2 IGF1R OVOL1 WIZ TRIM28 PPP1R15B EHMT1 LRP3 LRP5 AKAP13 HMGXB3 LTBP3 TNFAIP3 LTBP4 NOTCH1 NOTCH2 | 8.26e-10 | 1105 | 168 | 24 | 35748872 |
| Pubmed | ERBB4 ADAMTS1 NSD2 FAT3 GAS6 ZNF318 BCL11A CHAMP1 LDLR SETD2 RESF1 WIZ TRIM28 DROSHA LRP1 EHMT1 LRP2 ADAM17 TAF6 LTBP4 GARRE1 ZMYM3 NOTCH2 SORL1 | 1.00e-09 | 1116 | 168 | 24 | 31753913 | |
| Pubmed | 1.91e-09 | 12 | 168 | 5 | 15465494 | ||
| Pubmed | 2.62e-09 | 5 | 168 | 4 | 19047013 | ||
| Pubmed | 2.62e-09 | 5 | 168 | 4 | 23675950 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.62e-09 | 5 | 168 | 4 | 15064243 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 3.09e-09 | 13 | 168 | 5 | 11578869 | |
| Pubmed | 4.79e-09 | 14 | 168 | 5 | 14757642 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 5.03e-09 | 29 | 168 | 6 | 21402740 | |
| Pubmed | 7.15e-09 | 15 | 168 | 5 | 12971992 | ||
| Pubmed | 7.82e-09 | 6 | 168 | 4 | 10958687 | ||
| Pubmed | 1.04e-08 | 16 | 168 | 5 | 17273555 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.04e-08 | 16 | 168 | 5 | 12617809 | |
| Pubmed | 1.46e-08 | 17 | 168 | 5 | 18694942 | ||
| Pubmed | NPC1 ZNF473 MBNL1 NSD1 SHMT1 DIDO1 ZNF318 ADGRE2 LDLR MTMR6 ZSCAN10 RESF1 DNAAF10 ATRNL1 UNC5C LRP2 HMGXB3 ADAM17 TNFAIP3 CKAP2 KIF13A SLC33A1 | 1.50e-08 | 1084 | 168 | 22 | 11544199 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 10383933 | ||
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.82e-08 | 7 | 168 | 4 | 12846471 | |
| Pubmed | 1.82e-08 | 7 | 168 | 4 | 16169548 | ||
| Pubmed | 2.02e-08 | 18 | 168 | 5 | 15689374 | ||
| Pubmed | 2.02e-08 | 18 | 168 | 5 | 18093989 | ||
| Pubmed | 2.73e-08 | 19 | 168 | 5 | 16518823 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 3.62e-08 | 8 | 168 | 4 | 22652674 | |
| Pubmed | 3.62e-08 | 8 | 168 | 4 | 9858718 | ||
| Pubmed | 3.62e-08 | 8 | 168 | 4 | 11044610 | ||
| Pubmed | 4.54e-08 | 41 | 168 | 6 | 22675208 | ||
| Pubmed | 4.74e-08 | 21 | 168 | 5 | 28656980 | ||
| Pubmed | 6.10e-08 | 22 | 168 | 5 | 21750033 | ||
| Pubmed | 6.50e-08 | 9 | 168 | 4 | 11118901 | ||
| Pubmed | ZNF787 SP2 DTX3 MBNL1 DIDO1 ZNF318 BCL11A ZNF467 CHAMP1 RING1 AHRR OVOL1 TRIM28 HMGXB3 PAX4 ZMYM3 FOXD4 | 7.09e-08 | 709 | 168 | 17 | 22988430 | |
| Pubmed | 7.77e-08 | 23 | 168 | 5 | 24337118 | ||
| Pubmed | 7.77e-08 | 23 | 168 | 5 | 14701881 | ||
| Pubmed | 1.08e-07 | 10 | 168 | 4 | 24015274 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 38891114 | ||
| Pubmed | Triggering of a Dll4-Notch1 loop impairs wound healing in diabetes. | 1.11e-07 | 3 | 168 | 3 | 30886104 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 27697639 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 31005376 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 28572448 | ||
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 1.11e-07 | 3 | 168 | 3 | 11944992 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 1.11e-07 | 3 | 168 | 3 | 17035546 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 1.11e-07 | 3 | 168 | 3 | 25423136 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7615640 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7918097 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 30858964 | ||
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 1.11e-07 | 3 | 168 | 3 | 18458347 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 33351914 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 1.11e-07 | 3 | 168 | 3 | 29767458 | |
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 1.11e-07 | 3 | 168 | 3 | 12036300 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 1.11e-07 | 3 | 168 | 3 | 29045040 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 7698746 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 38571813 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 35173587 | ||
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 1.11e-07 | 3 | 168 | 3 | 37330998 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 8645602 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 16406382 | ||
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 1.11e-07 | 3 | 168 | 3 | 26446217 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 1.11e-07 | 3 | 168 | 3 | 34133920 | |
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 1.11e-07 | 3 | 168 | 3 | 27073072 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 1.11e-07 | 3 | 168 | 3 | 21471519 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 28013231 | ||
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 31812984 | ||
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 1.11e-07 | 3 | 168 | 3 | 26213384 | |
| Pubmed | 1.11e-07 | 3 | 168 | 3 | 31469403 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 1.11e-07 | 3 | 168 | 3 | 7722633 | |
| Pubmed | 1.20e-07 | 48 | 168 | 6 | 35247391 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.50e-07 | 26 | 168 | 5 | 19369401 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 1.69e-07 | 11 | 168 | 4 | 16607638 | |
| Pubmed | 1.69e-07 | 11 | 168 | 4 | 10878608 | ||
| Pubmed | 1.69e-07 | 11 | 168 | 4 | 12866128 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.84e-07 | 27 | 168 | 5 | 21791528 | |
| Pubmed | 2.68e-07 | 29 | 168 | 5 | 25535917 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 3.20e-07 | 30 | 168 | 5 | 24552588 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 NSD2 WRN NSD1 ZNF205 DIDO1 ZNF318 FANCM CHAMP1 LDLR THOC6 RING1 SETD2 WIZ TRIM28 ASPH RNF20 EHMT1 CKAP2 TAF6 TET3 ZMYM3 | 3.23e-07 | 1294 | 168 | 22 | 30804502 |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 3.63e-07 | 13 | 168 | 4 | 31202705 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 ITGA1 ADGRE2 ADAM12 LDLR JAG2 IGF1R TENM3 TRIM28 ASPH RIMOC1 LRP1 LRP5 ADAM17 LTBP3 CKAP2 SLC33A1 NOTCH1 NOTCH2 NOTCH3 SORL1 | 3.90e-07 | 1201 | 168 | 21 | 35696571 |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 28669409 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 11401408 | ||
| Pubmed | Selective modulation of integrin-mediated cell migration by distinct ADAM family members. | 4.41e-07 | 4 | 168 | 3 | 16079176 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 4.41e-07 | 4 | 168 | 3 | 8898100 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 11978185 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 8786425 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 36325910 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 4.41e-07 | 4 | 168 | 3 | 17920003 | |
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 4.41e-07 | 4 | 168 | 3 | 33888718 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 24398584 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 4.41e-07 | 4 | 168 | 3 | 28061457 | |
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 4.41e-07 | 4 | 168 | 3 | 32820046 | |
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 11466531 | ||
| Pubmed | 4.41e-07 | 4 | 168 | 3 | 24151014 | ||
| Pubmed | SorLA controls neurotrophic activity by sorting of GDNF and its receptors GFRα1 and RET. | 4.41e-07 | 4 | 168 | 3 | 23333276 | |
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 4.41e-07 | 4 | 168 | 3 | 32134527 | |
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 4.41e-07 | 4 | 168 | 3 | 18184405 | |
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 4.41e-07 | 4 | 168 | 3 | 20040020 | |
| Interaction | NTN5 interactions | 1.02e-11 | 24 | 163 | 8 | int:NTN5 | |
| Interaction | FBXO2 interactions | NPC1 GAS6 SHMT1 LAMC2 ITGA1 LEPR JAG2 IGF1R TENM3 LRP2 ADAM17 IL17RA PAX4 OLFM2 LTBP4 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.01e-09 | 411 | 163 | 19 | int:FBXO2 |
| Interaction | ZDHHC15 interactions | THSD7A ZNF318 ZNF77 RESF1 NRXN1 ATRNL1 LRP1 LRP2 LTBP3 MUC5AC SPINK5 | 5.79e-09 | 125 | 163 | 11 | int:ZDHHC15 |
| Interaction | ZNF74 interactions | 8.91e-09 | 34 | 163 | 7 | int:ZNF74 | |
| Interaction | PRG2 interactions | ADAMTS1 GAS6 LAMC2 LDLR JAG2 LRP5 IL17RA LTBP3 OLFM2 LTBP4 NOTCH1 ZMYM3 NOTCH2 NOTCH3 SORL1 | 1.15e-08 | 285 | 163 | 15 | int:PRG2 |
| Interaction | IGFL3 interactions | 1.64e-07 | 75 | 163 | 8 | int:IGFL3 | |
| Interaction | EGFL7 interactions | 2.02e-07 | 77 | 163 | 8 | int:EGFL7 | |
| Interaction | EDN3 interactions | 2.34e-07 | 108 | 163 | 9 | int:EDN3 | |
| Interaction | CCN6 interactions | 3.45e-07 | 19 | 163 | 5 | int:CCN6 | |
| Interaction | ZFP41 interactions | 3.75e-07 | 57 | 163 | 7 | int:ZFP41 | |
| Interaction | ZNF627 interactions | 4.57e-07 | 20 | 163 | 5 | int:ZNF627 | |
| Interaction | WNT10A interactions | 4.82e-07 | 37 | 163 | 6 | int:WNT10A | |
| Interaction | SDF2L1 interactions | NPC1 ADAM19 GRK6 GAS6 ZNRF4 JAG2 IGF1R LRP5 ADAM17 IL17RA OLFM2 ALK SORL1 | 2.29e-06 | 322 | 163 | 13 | int:SDF2L1 |
| Interaction | WNT3A interactions | 2.68e-06 | 49 | 163 | 6 | int:WNT3A | |
| Interaction | ZNF408 interactions | 2.81e-06 | 145 | 163 | 9 | int:ZNF408 | |
| Interaction | IGSF5 interactions | 3.88e-06 | 14 | 163 | 4 | int:IGSF5 | |
| Interaction | TIMP3 interactions | 8.47e-06 | 90 | 163 | 7 | int:TIMP3 | |
| Interaction | CFC1 interactions | 8.63e-06 | 126 | 163 | 8 | int:CFC1 | |
| Interaction | LGALS1 interactions | NPC1 FAT3 ITGA1 LDLR JAG2 IGF1R TENM3 LRP2 NOTCH1 NOTCH2 NOTCH3 SORL1 | 1.72e-05 | 332 | 163 | 12 | int:LGALS1 |
| Interaction | ZNF224 interactions | 1.81e-05 | 20 | 163 | 4 | int:ZNF224 | |
| Interaction | SLURP1 interactions | 2.29e-05 | 144 | 163 | 8 | int:SLURP1 | |
| Interaction | ZNF324 interactions | 3.41e-05 | 46 | 163 | 5 | int:ZNF324 | |
| Interaction | TAFA2 interactions | 3.79e-05 | 47 | 163 | 5 | int:TAFA2 | |
| Interaction | ZNF761 interactions | 4.21e-05 | 9 | 163 | 3 | int:ZNF761 | |
| Interaction | ZNF480 interactions | 4.21e-05 | 9 | 163 | 3 | int:ZNF480 | |
| Interaction | ZNF587B interactions | 4.21e-05 | 9 | 163 | 3 | int:ZNF587B | |
| Interaction | ZNF707 interactions | 4.36e-05 | 79 | 163 | 6 | int:ZNF707 | |
| Interaction | TRIM66 interactions | 4.53e-05 | 205 | 163 | 9 | int:TRIM66 | |
| Interaction | PIGA interactions | 4.66e-05 | 49 | 163 | 5 | int:PIGA | |
| Interaction | FOXD4L6 interactions | 4.66e-05 | 49 | 163 | 5 | int:FOXD4L6 | |
| Interaction | LYZL1 interactions | 4.95e-05 | 118 | 163 | 7 | int:LYZL1 | |
| Interaction | ADAM32 interactions | 5.37e-05 | 26 | 163 | 4 | int:ADAM32 | |
| Interaction | SIRPD interactions | 7.04e-05 | 86 | 163 | 6 | int:SIRPD | |
| Interaction | ZSCAN21 interactions | 8.29e-05 | 128 | 163 | 7 | int:ZSCAN21 | |
| Interaction | ZNF517 interactions | 8.37e-05 | 29 | 163 | 4 | int:ZNF517 | |
| Interaction | ZNF563 interactions | 1.08e-04 | 12 | 163 | 3 | int:ZNF563 | |
| Interaction | ANKRD36B interactions | 1.24e-04 | 60 | 163 | 5 | int:ANKRD36B | |
| Interaction | ZNF382 interactions | 1.41e-04 | 33 | 163 | 4 | int:ZNF382 | |
| Interaction | ZNF101 interactions | 1.41e-04 | 33 | 163 | 4 | int:ZNF101 | |
| Interaction | NOTCH2 interactions | ZNF787 SP2 ADAMTS1 DTX3 DLK1 JAG2 ASPH LTBP4 GARRE1 NOTCH1 NOTCH2 NOTCH3 | 1.75e-04 | 423 | 163 | 12 | int:NOTCH2 |
| Interaction | SOST interactions | 1.78e-04 | 35 | 163 | 4 | int:SOST | |
| Interaction | OIT3 interactions | 1.82e-04 | 65 | 163 | 5 | int:OIT3 | |
| Interaction | APBB1 interactions | 1.92e-04 | 195 | 163 | 8 | int:APBB1 | |
| Interaction | CLEC2B interactions | 1.96e-04 | 147 | 163 | 7 | int:CLEC2B | |
| Interaction | DLK2 interactions | 1.99e-04 | 36 | 163 | 4 | int:DLK2 | |
| Interaction | GREM2 interactions | 2.21e-04 | 37 | 163 | 4 | int:GREM2 | |
| Interaction | PPP1R12B interactions | 2.25e-04 | 68 | 163 | 5 | int:PPP1R12B | |
| Interaction | MARCHF1 interactions | 2.58e-04 | 70 | 163 | 5 | int:MARCHF1 | |
| Interaction | ZNF813 interactions | 2.69e-04 | 16 | 163 | 3 | int:ZNF813 | |
| Interaction | ADAM23 interactions | 2.69e-04 | 16 | 163 | 3 | int:ADAM23 | |
| Interaction | TOP3B interactions | NPC1 SPIRE2 NSD2 GRK6 WRN NSD1 LDLR PLEKHM1 DHX30 JAG2 IGF1R OVOL1 WIZ TRIM28 PPP1R15B EHMT1 LRP3 LRP5 AKAP13 HMGXB3 LTBP3 TNFAIP3 LTBP4 NOTCH1 NOTCH2 | 3.20e-04 | 1470 | 163 | 25 | int:TOP3B |
| Interaction | MAML2 interactions | 3.25e-04 | 17 | 163 | 3 | int:MAML2 | |
| Interaction | JAG1 interactions | 3.31e-04 | 41 | 163 | 4 | int:JAG1 | |
| Cytoband | 5q35 | 8.08e-05 | 23 | 168 | 3 | 5q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 1.67e-04 | 139 | 168 | 5 | chr5p13 | |
| GeneFamily | Low density lipoprotein receptors | 1.59e-08 | 13 | 122 | 5 | 634 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF787 SP2 ZNF266 ZNF473 ZNF205 ZNF318 BCL11A ZNF467 CHAMP1 ZNF77 ZNF16 OVOL1 ZSCAN10 WIZ ZFP92 ZNF415 | 2.64e-05 | 718 | 122 | 16 | 28 |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.07e-05 | 27 | 122 | 4 | 47 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 7.82e-05 | 34 | 122 | 4 | 487 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 2.69e-04 | 4 | 122 | 2 | 628 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.40e-04 | 394 | 122 | 10 | 471 | |
| GeneFamily | CD molecules|Adhesion G protein-coupled receptors, subfamily E | 4.46e-04 | 5 | 122 | 2 | 915 | |
| GeneFamily | PHD finger proteins | 3.23e-03 | 90 | 122 | 4 | 88 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.73e-08 | 16 | 164 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.73e-08 | 16 | 164 | 5 | M2207 | |
| Coexpression | GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN | 4.80e-06 | 199 | 164 | 9 | M8070 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 5.00e-06 | 200 | 164 | 9 | M4948 | |
| Coexpression | NABA_MATRISOME | ADAM19 ADAMTS1 GAS6 LAMC2 ADAM29 TECTA VWCE ADAM12 GDNF ADAMTS12 EYS SEMA5B WNT16 CST5 SCUBE3 ADAM17 LTBP3 LTBP4 MUC5AC ANGPTL5 | 6.96e-06 | 1026 | 164 | 20 | M5889 |
| Coexpression | WANG_TNF_TARGETS | 1.98e-05 | 26 | 164 | 4 | M2308 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN | 3.68e-05 | 198 | 164 | 8 | M5847 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN | 3.81e-05 | 199 | 164 | 8 | M5845 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN | 3.95e-05 | 200 | 164 | 8 | M9373 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 3.95e-05 | 200 | 164 | 8 | M6477 | |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | TRAF1 ADAM19 PDSS1 EML4 RNF19B SAMSN1 ADGRE2 VPS9D1 CSF3R ARFGAP3 PPP1R15B ASPH ADAM17 TNFAIP3 NOTCH2 | 5.30e-05 | 724 | 164 | 15 | M41700 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 5.95e-05 | 212 | 164 | 8 | M39221 | |
| Coexpression | NABA_MATRISOME | ADAM19 ADAMTS1 GAS6 LAMC2 ADAM29 TECTA VWCE ADAM12 GDNF ADAMTS12 SEMA5B WNT16 CST5 SCUBE3 ADAM17 LTBP3 LTBP4 MUC5AC | 6.44e-05 | 1008 | 164 | 18 | MM17056 |
| Coexpression | GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN | 9.38e-05 | 168 | 164 | 7 | M5662 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | THSD7A ADAMTS1 GAS6 ITGA1 ADAM12 LEPR ADAMTS12 TENM3 ATRNL1 LRP1 LTBP3 C7 LTBP4 RECK NOTCH3 | 3.25e-06 | 466 | 163 | 15 | GSM777050_500 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GFRA1 ADAMTS12 TENM3 ATRNL1 UNC5C LRP1 C7 LTBP4 | 2.65e-09 | 191 | 165 | 10 | a58c75e9580139fb370b498d95660f10f3a2a27b |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GFRA1 ADAMTS12 TENM3 ATRNL1 UNC5C LRP1 C7 LTBP4 | 2.79e-09 | 192 | 165 | 10 | 9093a9e94a25682d109a7f6edc256a25a61103a0 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GFRA1 ADAMTS12 TENM3 ATRNL1 UNC5C LRP1 C7 LTBP4 | 2.79e-09 | 192 | 165 | 10 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GFRA1 ADAMTS12 TENM3 ATRNL1 UNC5C LRP1 C7 LTBP4 | 2.93e-09 | 193 | 165 | 10 | f1199518c3626fd29bfce65070dd21a660671213 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-09 | 194 | 165 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GDNF GFRA1 ADAMTS12 NRXN3 TENM3 ATRNL1 UNC5C C7 | 3.08e-09 | 194 | 165 | 10 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ITGA1 ADAM12 GDNF GFRA1 ADAMTS12 NRXN3 TENM3 ATRNL1 UNC5C C7 | 3.08e-09 | 194 | 165 | 10 | df82cce5ebeb73740b02cf816c6df82253cfd566 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-09 | 199 | 165 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-08 | 189 | 165 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-08 | 189 | 165 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-08 | 190 | 165 | 9 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-08 | 190 | 165 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.01e-08 | 190 | 165 | 9 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.20e-08 | 191 | 165 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 191 | 165 | 9 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 191 | 165 | 9 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 191 | 165 | 9 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.20e-08 | 191 | 165 | 9 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-08 | 192 | 165 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-08 | 192 | 165 | 9 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-08 | 192 | 165 | 9 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-08 | 193 | 165 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-08 | 194 | 165 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.80e-08 | 194 | 165 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-08 | 195 | 165 | 9 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-08 | 195 | 165 | 9 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-08 | 195 | 165 | 9 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-08 | 195 | 165 | 9 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 196 | 165 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 196 | 165 | 9 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 196 | 165 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.24e-08 | 196 | 165 | 9 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-08 | 197 | 165 | 9 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-08 | 197 | 165 | 9 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-08 | 197 | 165 | 9 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.47e-08 | 197 | 165 | 9 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 5.71e-08 | 198 | 165 | 9 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.23e-08 | 200 | 165 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-08 | 145 | 165 | 8 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 163 | 165 | 8 | abec4389cd88252449f110fe95416d67424b403a | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.32e-07 | 177 | 165 | 8 | 59726bfd98f656fdcedf448a7e2e76a9bfad8285 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 181 | 165 | 8 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 181 | 165 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 181 | 165 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-07 | 184 | 165 | 8 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-07 | 184 | 165 | 8 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-07 | 185 | 165 | 8 | f607b6ee579562e2f92103fa5c7053df0170a229 | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-07 | 185 | 165 | 8 | 317f2c854f00aa5957319b818c85eeed7d72ec7f | |
| ToppCell | 5'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-07 | 185 | 165 | 8 | 7bb8fdfe04f85d25056380ec58222366de323a21 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.04e-07 | 187 | 165 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.46e-07 | 189 | 165 | 8 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.46e-07 | 189 | 165 | 8 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.46e-07 | 189 | 165 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.69e-07 | 190 | 165 | 8 | 57800d807785b9d539b47945a0a74631f5e88a06 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.69e-07 | 190 | 165 | 8 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 191 | 165 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.92e-07 | 191 | 165 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 191 | 165 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-07 | 192 | 165 | 8 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-07 | 192 | 165 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-07 | 192 | 165 | 8 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 192 | 165 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 192 | 165 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.15e-07 | 192 | 165 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.15e-07 | 192 | 165 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 193 | 165 | 8 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 193 | 165 | 8 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | 81713e0409e8be695ba5dfdc67a997b33435dd9e | |
| ToppCell | Control-Classical_Monocyte|Control / Disease condition and Cell class | 6.66e-07 | 194 | 165 | 8 | 9e33e1b54b4114f9e6981819834bb796ed7192b5 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-07 | 194 | 165 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | 627cffe2d448e74fc5df92e74e5b922a73304137 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | cf0244a29934e515446ac917d3c30672b460fb04 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-07 | 194 | 165 | 8 | ba7f971fb9a19423602da60770f23d9fead4a451 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 6.66e-07 | 194 | 165 | 8 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | distal-Hematologic-Classical_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.92e-07 | 195 | 165 | 8 | 32c34741e35006b7238896fd04a497011297dd22 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-07 | 195 | 165 | 8 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 6.92e-07 | 195 | 165 | 8 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-07 | 195 | 165 | 8 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.92e-07 | 195 | 165 | 8 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.92e-07 | 195 | 165 | 8 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 6.92e-07 | 195 | 165 | 8 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 196 | 165 | 8 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.19e-07 | 196 | 165 | 8 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-07 | 196 | 165 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.19e-07 | 196 | 165 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-07 | 197 | 165 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.47e-07 | 197 | 165 | 8 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-07 | 197 | 165 | 8 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-07 | 197 | 165 | 8 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.47e-07 | 197 | 165 | 8 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.47e-07 | 197 | 165 | 8 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 7.47e-07 | 197 | 165 | 8 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-07 | 198 | 165 | 8 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.06e-07 | 199 | 165 | 8 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.06e-07 | 199 | 165 | 8 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.06e-07 | 199 | 165 | 8 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.06e-07 | 199 | 165 | 8 | 119807ea333d1dc7743c6b9f03a2c63e09e19541 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.06e-07 | 199 | 165 | 8 | 691e04871cd6cac0ea5fca1b7fd6421df9315db6 | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 4.76e-07 | 171 | 164 | 10 | 2723_DN | |
| Drug | Androgen Antagonists | 1.16e-06 | 75 | 164 | 7 | ctd:D000726 | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | ZNF473 LAMC2 RO60 ADAM12 LDLR JAG2 ZNF16 TENM3 ADAM17 MUC5AC | 1.37e-06 | 192 | 164 | 10 | 6659_DN |
| Drug | monatepil | 1.88e-06 | 29 | 164 | 5 | CID000060810 | |
| Drug | Dichlorodiphenyl Dichloroethylene | ERBB4 GDNF LDLR GFRA1 GJB1 IGF1R NRXN1 NRXN2 SYP ALK NOTCH2 NOTCH3 | 2.08e-06 | 302 | 164 | 12 | ctd:D003633 |
| Drug | Linuron | 4.20e-06 | 128 | 164 | 8 | ctd:D008044 | |
| Drug | enzacamene | 4.45e-06 | 129 | 164 | 8 | ctd:C038939 | |
| Drug | octylmethoxycinnamate | 7.73e-06 | 139 | 164 | 8 | ctd:C118580 | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.35e-05 | 197 | 164 | 9 | 3355_UP | |
| Drug | Dubinidine [22964-77-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 6250_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.41e-05 | 198 | 164 | 9 | 2286_DN | |
| Drug | butylparaben | 1.88e-05 | 157 | 164 | 8 | ctd:C038091 | |
| Drug | Tapi | 2.47e-05 | 80 | 164 | 6 | CID003035404 | |
| Drug | AC1L1GUQ | 2.97e-05 | 50 | 164 | 5 | CID000003849 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; PC3; HT_HG-U133A | 5.40e-05 | 182 | 164 | 8 | 2049_UP | |
| Drug | TAPI-1 | 5.64e-05 | 57 | 164 | 5 | CID009827273 | |
| Drug | Perphenazine [58-39-9]; Up 200; 10uM; PC3; HG-U133A | 6.06e-05 | 185 | 164 | 8 | 1956_UP | |
| Drug | Insulin recombinant | 7.70e-05 | 12 | 164 | 3 | DB00030 | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 8.15e-05 | 193 | 164 | 8 | 3677_DN | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 8.45e-05 | 194 | 164 | 8 | 6660_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 6522_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 3078_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 6648_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.76e-05 | 195 | 164 | 8 | 3923_DN | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 2712_UP | |
| Drug | 0393-0188; Down 200; 10uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 7510_DN | |
| Drug | nifedipine; Up 200; 10uM; MCF7; HG-U133A | 9.41e-05 | 197 | 164 | 8 | 335_UP | |
| Drug | Anabasine [494-52-0]; Up 200; 24.6uM; HL60; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 2512_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 9.41e-05 | 197 | 164 | 8 | 6341_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 2155_UP | |
| Drug | Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; PC3; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 6743_UP | |
| Drug | Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 4979_DN | |
| Drug | DO 897/99; Down 200; 8.2uM; MCF7; HT_HG-U133A | 9.74e-05 | 198 | 164 | 8 | 2877_DN | |
| Drug | Insulin, porcine | 9.95e-05 | 13 | 164 | 3 | DB00071 | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; HL60; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 2347_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 3544_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 3249_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.01e-04 | 199 | 164 | 8 | 2057_DN | |
| Drug | hydroxystilbamidine | 1.02e-04 | 103 | 164 | 6 | CID005353676 | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | 1.04e-04 | 200 | 164 | 8 | 1574_DN | |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; HL60; HT_HG-U133A | 1.04e-04 | 200 | 164 | 8 | 2984_UP | |
| Disease | Malignant neoplasm of breast | ERBB4 ANK2 ADAMTS1 DLL4 NSD2 DTX3 SHMT1 ZNF318 BCL11A TECTA ADAM12 LEPR JAG2 SETD2 IGF1R SEMA5B ARFGAP3 EHMT1 KLHDC7A ALK NOTCH1 NOTCH2 NOTCH3 PADI3 SORL1 | 8.41e-10 | 1074 | 160 | 25 | C0006142 |
| Disease | Schizophrenia | ERBB4 HTR2C GRK6 MBNL1 SHMT1 BCL11A GRM2 ADAM12 GDNF GFRA1 GFRA3 ADAMTS12 JAG2 NRXN3 NRXN1 NRXN2 UNC5C ERVK-8 LRP1 LRP2 SYP ALK | 2.82e-09 | 883 | 160 | 22 | C0036341 |
| Disease | Glioblastoma | 2.52e-07 | 79 | 160 | 7 | C0017636 | |
| Disease | Breast Carcinoma | ERBB4 ADAMTS1 DLL4 NSD2 DTX3 SHMT1 LEPR JAG2 SETD2 IGF1R KLHDC7A ALK NOTCH1 NOTCH2 NOTCH3 | 2.68e-07 | 538 | 160 | 15 | C0678222 |
| Disease | Giant Cell Glioblastoma | 3.86e-07 | 84 | 160 | 7 | C0334588 | |
| Disease | Mammary Carcinoma, Human | ADAMTS1 DLL4 NSD2 DTX3 SHMT1 LEPR JAG2 SETD2 IGF1R KLHDC7A ALK NOTCH1 NOTCH2 NOTCH3 | 1.15e-06 | 525 | 160 | 14 | C4704874 |
| Disease | Mammary Neoplasms, Human | ADAMTS1 DLL4 NSD2 DTX3 SHMT1 LEPR JAG2 SETD2 IGF1R KLHDC7A ALK NOTCH1 NOTCH2 NOTCH3 | 1.15e-06 | 525 | 160 | 14 | C1257931 |
| Disease | Mammary Neoplasms | ADAMTS1 DLL4 NSD2 DTX3 SHMT1 LEPR JAG2 SETD2 IGF1R KLHDC7A ALK NOTCH1 NOTCH2 NOTCH3 | 1.21e-06 | 527 | 160 | 14 | C1458155 |
| Disease | Glioblastoma Multiforme | 2.56e-06 | 111 | 160 | 7 | C1621958 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.39e-06 | 7 | 160 | 3 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.39e-06 | 7 | 160 | 3 | DOID:3620 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 1.74e-05 | 59 | 160 | 5 | C0007114 | |
| Disease | Skin Neoplasms | 1.74e-05 | 59 | 160 | 5 | C0037286 | |
| Disease | peak expiratory flow | ADAM19 EML4 PLCXD2 ITGA1 EYS IGF1R FIG4 LRP1 SYP LRP5 LTBP4 SORL1 | 1.89e-05 | 498 | 160 | 12 | EFO_0009718 |
| Disease | Non-Small Cell Lung Carcinoma | 2.39e-05 | 156 | 160 | 7 | C0007131 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.66e-05 | 32 | 160 | 4 | DOID:10155 (implicated_via_orthology) | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 2.92e-05 | 2 | 160 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | NSD2 NSD1 BCL11A PRRT2 CHAMP1 SETD2 NRXN1 NRXN2 LRP2 TAF6 TET3 | 3.51e-05 | 447 | 160 | 11 | C3714756 |
| Disease | hair color | 5.36e-05 | 311 | 160 | 9 | EFO_0003924 | |
| Disease | Impaired cognition | 5.45e-05 | 14 | 160 | 3 | C0338656 | |
| Disease | Lymphoma | 6.54e-05 | 40 | 160 | 4 | C0024299 | |
| Disease | cystatin C measurement | 7.32e-05 | 402 | 160 | 10 | EFO_0004617 | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 1.02e-04 | 85 | 160 | 5 | C1510586 | |
| Disease | hair colour measurement | TRAF1 SPIRE2 ADAMTS1 MBNL1 DCT ADAMTS12 VPS9D1 OVOL1 LRP1 LRP5 AKAP13 PADI3 | 1.42e-04 | 615 | 160 | 12 | EFO_0007822 |
| Disease | Fetal Growth Retardation | 1.67e-04 | 20 | 160 | 3 | C0015934 | |
| Disease | Squamous cell carcinoma of esophagus | 1.72e-04 | 95 | 160 | 5 | C0279626 | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 1.74e-04 | 4 | 160 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | superoxide dismutase [Mn]; mitochondrial measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0021981 | |
| Disease | Sotos' syndrome | 1.74e-04 | 4 | 160 | 2 | C0175695 | |
| Disease | Adenoid Cystic Carcinoma | 2.19e-04 | 100 | 160 | 5 | C0010606 | |
| Disease | Alzheimer's Disease | 2.29e-04 | 101 | 160 | 5 | C0002395 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 2.63e-04 | 57 | 160 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.75e-04 | 105 | 160 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 2.81e-04 | 58 | 160 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | polyarteritis nodosa (is_marker_for) | 2.89e-04 | 5 | 160 | 2 | DOID:9810 (is_marker_for) | |
| Disease | Churg-Strauss syndrome (is_marker_for) | 2.89e-04 | 5 | 160 | 2 | DOID:3049 (is_marker_for) | |
| Disease | Carcinoma, Pancreatic Ductal | 2.91e-04 | 24 | 160 | 3 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 3.71e-04 | 26 | 160 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | ADAM19 ADAMTS1 EML4 NSD1 LAMC2 BCL11A ITGA1 ADAM12 FCGBP SYTL4 WNT16 LRP1 SCUBE3 LTBP3 KIF13A LTBP4 SORL1 | 3.83e-04 | 1228 | 160 | 17 | EFO_0004713 |
| Disease | urate measurement | DNAH3 ERBB4 NSD1 ZNF318 STAB1 IGF1R OVOL1 MALRD1 NRXN1 NRXN2 LRP1 LRP2 AKAP13 NOTCH2 | 3.89e-04 | 895 | 160 | 14 | EFO_0004531 |
| Disease | Adams Oliver syndrome | 4.32e-04 | 6 | 160 | 2 | C0265268 | |
| Disease | response to diuretic, diastolic blood pressure change measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0006945, GO_0036270 | |
| Disease | Congenital defect of skull and scalp | 4.32e-04 | 6 | 160 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 4.32e-04 | 6 | 160 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 4.32e-04 | 6 | 160 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | DNAH3 ADAM19 ANK2 WRN ADAM29 TRIM28 WNT16 LRP1 LRP2 OLFM2 SLC33A1 SORL1 | 4.70e-04 | 702 | 160 | 12 | C0009402 |
| Disease | Mental Retardation, X-Linked | 5.15e-04 | 29 | 160 | 3 | C1136249 | |
| Disease | colorectal cancer, overall survival | 5.15e-04 | 29 | 160 | 3 | EFO_0000638, MONDO_0005575 | |
| Disease | uric acid measurement | DNAH3 ERBB4 FAT3 ZNF318 GJB1 IGF1R OVOL1 NRXN2 LRP2 AKAP13 ZMYM3 | 5.22e-04 | 610 | 160 | 11 | EFO_0004761 |
| Disease | colorectal cancer (implicated_via_orthology) | 5.70e-04 | 30 | 160 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Stage IV Skin Melanoma | 6.03e-04 | 7 | 160 | 2 | C1321872 | |
| Disease | osteoporosis (is_implicated_in) | 6.29e-04 | 31 | 160 | 3 | DOID:11476 (is_implicated_in) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.81e-04 | 128 | 160 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.81e-04 | 128 | 160 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.81e-04 | 128 | 160 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.81e-04 | 128 | 160 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.81e-04 | 128 | 160 | 5 | C0007134 | |
| Disease | Squamous cell carcinoma of lung | 6.91e-04 | 32 | 160 | 3 | C0149782 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.04e-04 | 195 | 160 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.13e-04 | 74 | 160 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Tinnitus | 7.31e-04 | 130 | 160 | 5 | HP_0000360 | |
| Disease | internet addiction disorder | 7.58e-04 | 33 | 160 | 3 | EFO_0803368 | |
| Disease | eosinophil percentage of leukocytes | TRAF1 ADAM19 LEPR SETD2 RESF1 CSF3R AKAP13 IL17RA TNFAIP3 MUC5AC TET3 NOTCH2 | 7.99e-04 | 746 | 160 | 12 | EFO_0007991 |
| Disease | clear cell renal cell carcinoma (is_implicated_in) | 8.01e-04 | 8 | 160 | 2 | DOID:4467 (is_implicated_in) | |
| Disease | gestational age | 9.56e-04 | 138 | 160 | 5 | EFO_0005112 | |
| Disease | Neoplastic Cell Transformation | 9.87e-04 | 139 | 160 | 5 | C0007621 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.03e-03 | 9 | 160 | 2 | DOID:264 (is_marker_for) | |
| Disease | Mental deterioration | 1.03e-03 | 9 | 160 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 1.03e-03 | 9 | 160 | 2 | C1270972 | |
| Disease | underweight body mass index status | 1.03e-03 | 9 | 160 | 2 | EFO_0005936 | |
| Disease | free androgen index | 1.04e-03 | 374 | 160 | 8 | EFO_0007005 | |
| Disease | late-onset Alzheimers disease | 1.11e-03 | 292 | 160 | 7 | EFO_1001870 | |
| Disease | neuroblastoma (is_implicated_in) | 1.28e-03 | 10 | 160 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.31e-03 | 148 | 160 | 5 | C0279702 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.43e-03 | 41 | 160 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.43e-03 | 41 | 160 | 3 | C0858252 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.47e-03 | 152 | 160 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Semantic-Pragmatic Disorder | 1.56e-03 | 11 | 160 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 1.56e-03 | 11 | 160 | 2 | C0751257 | |
| Disease | Language Delay | 1.56e-03 | 11 | 160 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.56e-03 | 11 | 160 | 2 | C0023014 | |
| Disease | atopic dermatitis (implicated_via_orthology) | 1.56e-03 | 11 | 160 | 2 | DOID:3310 (implicated_via_orthology) | |
| Disease | Speech Delay | 1.56e-03 | 11 | 160 | 2 | C0241210 | |
| Disease | Craniofacial Abnormalities | 1.65e-03 | 156 | 160 | 5 | C0376634 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.69e-03 | 157 | 160 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Amelogenesis Imperfecta | 1.86e-03 | 12 | 160 | 2 | C0002452 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | susceptibility to pneumonia measurement | 1.95e-03 | 97 | 160 | 4 | EFO_0008410 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.10e-03 | 99 | 160 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 2.13e-03 | 47 | 160 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | mitochondrial DNA measurement | 2.16e-03 | 328 | 160 | 7 | EFO_0006312 | |
| Disease | Familial Alzheimer Disease (FAD) | 2.18e-03 | 100 | 160 | 4 | C0276496 | |
| Disease | homostachydrine measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0021164 | |
| Disease | Migraine Disorders | 2.19e-03 | 13 | 160 | 2 | C0149931 | |
| Disease | Granulomatosis with Polyangiitis | 2.19e-03 | 13 | 160 | 2 | EFO_0005297 | |
| Disease | coronary artery disease | NPC1 ZNF787 ERBB4 ADAM19 THSD7A ITGA1 LDLR ZNF77 MALRD1 NRXN1 UNC5C LRP1 AKAP13 TNKS ALK | 2.20e-03 | 1194 | 160 | 15 | EFO_0001645 |
| Disease | serum IgG glycosylation measurement | 2.30e-03 | 523 | 160 | 9 | EFO_0005193 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKECVGASNQNCRTP | 476 | O00400 | |
| QSCTCRAAEAAPVVK | 646 | A9YTQ3 | |
| LNSNCSPAFCNKRGI | 621 | Q9UKF5 | |
| QSPDLESSKCLTQGC | 51 | Q96M42 | |
| IFDDSCCNGTLRKPV | 1101 | Q15303 | |
| RGCCRDPNAQSSFSK | 411 | A0A096LP49 | |
| LRSVPTNKVCFDCGA | 16 | Q9NP61 | |
| DTRQRKCPKCNAAFG | 951 | Q5VTR2 | |
| DECQQNPRLCKSYGT | 121 | Q9UHX3 | |
| EQARQCDLPEFCTGK | 476 | Q9H013 | |
| PASRCSEPCLQNEVK | 496 | Q14416 | |
| CCKRNTAEEENSANP | 266 | P28335 | |
| DQDSCLQSLPDCGVK | 396 | Q12802 | |
| GSNCEKKVDRCTSNP | 396 | Q9NR61 | |
| EDCQLKPAGTACRDS | 471 | O43184 | |
| RPACLVNGQSVKSCS | 311 | Q86XS5 | |
| RNENACKGAPKTCTL | 636 | Q12797 | |
| ERINPKDRCESCSGA | 186 | Q8WW22 | |
| LVGKPSDCTLASAQC | 991 | Q7L2E3 | |
| PCANNRTCVSLDDGL | 96 | P80370 | |
| GCQAQLPSCESISEK | 341 | Q9H7Y0 | |
| TRKDICAGFNRPCET | 346 | P58397 | |
| TFSECLNLINEGCPK | 426 | Q8WWK9 | |
| SAQAPDGKCICTAVI | 36 | O95897 | |
| CLDSAGPRLNVCDKS | 1226 | Q96L73 | |
| TADLSEIPRCNCKAT | 1886 | Q96L73 | |
| ANELCEVNRKGCPSG | 501 | O95980 | |
| RSCNLEDCPDNNGKT | 606 | Q9UHI8 | |
| CRDINGQPASECAKE | 881 | Q9UHI8 | |
| PNCKRTVCLETGSQN | 326 | Q96EP9 | |
| PKRQDDCTGSCSVAL | 2321 | Q01484 | |
| IDIDECASNPCRKGA | 681 | Q04721 | |
| PGLNCTVKNSTCLDD | 46 | Q96F46 | |
| LPECQEDAGNKVCSL | 1451 | P46531 | |
| LSPPCDCRKEEAANQ | 621 | Q8IVU1 | |
| PCKNNGTCVDLTNRF | 936 | Q5T1H1 | |
| KEAAICRCSQPLSGF | 196 | Q9Y217 | |
| CDGLRCGDNTKAAVI | 216 | Q8N335 | |
| CKSSNPEQDVCSAFR | 151 | Q9NQ38 | |
| QLDANECEGKPCLNA | 421 | Q9Y219 | |
| TPGSRQCACAEDQVL | 821 | Q07954 | |
| SSTQFKCNSGRCIPE | 1016 | Q07954 | |
| NDLSRGACPAAEIKC | 196 | Q8IYD8 | |
| IKQQCDSFPDCIDGS | 1351 | O75197 | |
| DCLSTSSRGICPKQE | 111 | Q9H165 | |
| PDKRGLCVCSSFDQT | 331 | Q96MX6 | |
| ICPSCGVNLAKDRTE | 641 | Q12766 | |
| PSTCGKRACTENNEC | 216 | P08069 | |
| KLSPENVAAACEDGC | 26 | P35913 | |
| CPQGNNESCTDVAKE | 841 | Q6ZU69 | |
| ANGKTPSCEVNRECS | 31 | O96028 | |
| DCPSAKNDDACLVPN | 196 | Q96PG2 | |
| GVAPFCSRETLKQCA | 681 | Q9P2S2 | |
| CIRINCNSSKGPETL | 751 | Q9Y4C0 | |
| DVNECLSGPCRNQAT | 431 | Q9UM47 | |
| RCNNQKSCPDGADEK | 436 | O75074 | |
| DRNCSLCADNIEGKT | 96 | P48357 | |
| SDKVGQACCRPIAFD | 171 | P39905 | |
| TSDEKNCPDRTCQSG | 2811 | P98164 | |
| PSDKNCQSCLCTERG | 1251 | P98088 | |
| NLDCIRINCNSSKGP | 781 | Q9ULB1 | |
| GCKLTICPQAENRND | 331 | Q9ULW8 | |
| NSGICRASCKKNEQP | 31 | Q8N690 | |
| NSCTTENKNEPCGAR | 556 | P56199 | |
| EDCANGCAPTKGAVL | 371 | Q12950 | |
| DSPSGDLFTCRVCQK | 111 | O14753 | |
| SCERNCRPVNASKDI | 666 | Q7Z442 | |
| QLCAEGLCTQDKTPS | 106 | O43316 | |
| KPQSSCCRVDNITDQ | 951 | O15118 | |
| RKLCSADEFPCTSGQ | 431 | Q5VYJ5 | |
| KANCSPEDPCQETVS | 96 | Q7Z6L0 | |
| ISSKDICQDRAGNCP | 101 | A6NGY1 | |
| DAPGSCLIDCNENTR | 106 | P87889 | |
| DAPGSCLIDCNENTR | 106 | P62685 | |
| ESTCPICLGEIQNAK | 161 | Q8N9I9 | |
| PRCAVKSCDDFLGQL | 1251 | P17927 | |
| PAVIKNVSSACEGLC | 2871 | Q8TD57 | |
| NCQPESRSVSSCLKE | 266 | P56159 | |
| QARRKCQADPTCSAA | 46 | O60609 | |
| CDRKSCGNRNETPSD | 166 | Q9BQW3 | |
| CECPEAAKQSATNGV | 196 | Q6ZN03 | |
| IANSCKAVSVLGCPD | 271 | Q5T2R2 | |
| RDKQSCPAGERCSVQ | 836 | Q9Y6R7 | |
| QQPCSRCSDGVIKLT | 836 | Q92562 | |
| GQSLLKCPRCNFESN | 761 | Q96JM3 | |
| TPNPCDRKGTQACQD | 121 | Q14393 | |
| PKAIEASLQGCCSEA | 306 | O15063 | |
| PCVQGKKTRSRECNN | 511 | P10643 | |
| CGPSLDVCAQDERSK | 721 | P10643 | |
| AVSPCRSDCDSIRKN | 4291 | Q8TDW7 | |
| GRTTCTKSQPNLDNC | 91 | P28325 | |
| LNCKICTGQVPSAED | 851 | Q9BTC0 | |
| QVSQSKPCERTGSCF | 56 | Q5VV63 | |
| DEKSSFICNTLQPGC | 46 | P08034 | |
| CPRTTQQSPEDCDFK | 86 | P49913 | |
| NCQTQGDSILDCVPK | 166 | Q99062 | |
| QRCPTDGTAAFKEIC | 441 | Q9NS15 | |
| GRKCQDIDECSQDPS | 861 | Q9NS15 | |
| EFQRGTCSRPDTECK | 21 | Q9NR56 | |
| RDQVCKSGVCVNTAP | 1261 | Q8N2S1 | |
| SKRAEAPQGCSCENP | 86 | Q5VTJ3 | |
| AGCTQDQRLLDSKCD | 126 | Q13753 | |
| PNGCKLIRNRSDCKD | 751 | Q9HC35 | |
| VTNCTQRLEQGPCKD | 126 | P43250 | |
| ACECRPGFELTKNQR | 181 | Q8IX30 | |
| ARGEPQQDCCVKTEL | 11 | Q9H9B1 | |
| DCIVTALRSGNKECP | 71 | Q06587 | |
| CAVFGLPSQDACQKA | 231 | Q8NGJ2 | |
| SIACNKNTCPGDRSA | 381 | P34896 | |
| PKENARSCVNGTLVC | 506 | Q9H1H9 | |
| RKNCSLGALDQACVP | 486 | Q9Y4G2 | |
| CQESLGRLSPKTNTC | 66 | Q96C24 | |
| PVCRQTGNTCKELRD | 181 | P08247 | |
| CVGSCEAKRAEALQS | 231 | P49848 | |
| QQCCLTLRTEGKEPD | 1266 | Q9NRR4 | |
| LPKANNSRSCRCPED | 1031 | Q92673 | |
| ASCPKLTCEREGCQT | 221 | Q6ZMZ0 | |
| GRSCPNAVEKEPCNL | 1201 | Q9UPZ6 | |
| VLGNKPATRQDCCQS | 96 | Q17RQ9 | |
| CGEEKECSNPSNLLE | 51 | A6NDU8 | |
| QCSPLDTNSCKQGER | 1206 | Q9HCM1 | |
| LNKSQLDDCPRDSGC | 326 | Q9NSI8 | |
| QGKGEAACQELLRCA | 66 | O60936 | |
| ARLQCPKCVFGTNSS | 351 | O95785 | |
| SGLQPSCDVNKRRCF | 1361 | Q14191 | |
| SCDVNKRRCFPGSEE | 1366 | Q14191 | |
| QNNLEECLQSCRKPG | 1626 | Q9P2P6 | |
| SCKVQLLGSQESECP | 606 | Q5SWA1 | |
| PGNSEVSLVCEKLCN | 296 | P10155 | |
| NTPSQIDSSCCIGKE | 576 | Q8TEV9 | |
| CAQGEDESQMCRKLP | 461 | Q9UM73 | |
| VRCKDIDECSQSPQP | 76 | Q14246 | |
| CTLKEGVQCSDRNSP | 506 | P78536 | |
| AICPACNSTLSGKLD | 46 | Q9NPC3 | |
| PRQCKSDEECALRNG | 1461 | O75443 | |
| EEPRKPNCQGSCKSQ | 1086 | Q5VYP0 | |
| CPECGKAFSRSSNLI | 266 | A6NM28 | |
| AGVCPADNVRCFKSD | 31 | Q8WWY7 | |
| VEKPCNCQDSRTASV | 186 | Q15935 | |
| CNAGKSCPRADVTLE | 81 | Q96SZ4 | |
| LDPGKCQACLQDVTR | 516 | P21580 | |
| VCSGTNPRKCQDLGD | 11 | A0A1B0GUW6 | |
| SIPCNNRTFKCGNDI | 556 | Q7RTY8 | |
| QEAFGNKLCPACSVE | 181 | Q0VAA5 | |
| TCPNCKDGEKRSGEQ | 506 | Q02086 | |
| SLPCILNACSGDAKS | 371 | Q8WWL2 | |
| KLCTPENINCRDTQG | 821 | O95271 | |
| RSCPVCKQSVAATED | 346 | Q8WWF5 | |
| DTDECLGTPCQQRCK | 181 | Q96DN2 | |
| APECKVLTAAGNSCR | 311 | Q86W42 | |
| DQICPKCRGEDLQSI | 51 | Q13077 | |
| CTQGFQLQDTPRKSC | 1281 | Q9NY15 | |
| PRKCDPNANCVQDSA | 1421 | Q9NY15 | |
| RTCELLDPCSKNNGG | 1536 | Q9NY15 | |
| RDCSEINNCLLPSAG | 906 | Q8WWQ8 | |
| VAGIPSECDCKNDAN | 1441 | Q9P273 | |
| GCANLPLNSRQKELC | 46 | Q9UBV4 | |
| PGAACSQNTNKTCEE | 36 | P53801 | |
| KSREERFCNENTPCP | 706 | Q9P283 | |
| NDDRTCACQGKDPNT | 961 | O43151 | |
| VNKECCPRLGAESAN | 36 | P40126 | |
| TSENEAIKRCCSPPN | 521 | Q9BYW2 | |
| PECGKCFSQRSNLIA | 451 | O95201 | |
| CNECGKSFSVRPNLT | 546 | Q09FC8 | |
| ECNDCGKPFSRVSNL | 406 | P17020 | |
| CSGVACLVKDNPQRS | 61 | O00401 | |
| EGLNTAASKDRCLAC | 431 | Q9Y2B5 | |
| DPADQSVQCVPKATC | 51 | Q9UI38 | |
| DCDGLVLQSKNCTDG | 351 | O95185 | |
| QKVCEENSVSPIGCN | 2041 | Q5VUA4 | |
| GDPADATRCSICQKT | 401 | Q14202 | |
| AEAPCRGQACSAQKA | 66 | Q7Z7K2 | |
| LDDSATICRVCQKPG | 621 | Q13263 | |
| PLVCNECGKTFRQSS | 701 | Q8WTR7 | |
| ERPNACADCGKTFSQ | 91 | Q6DD87 | |
| NPDVVCQRTCTGEKA | 141 | Q14584 | |
| EQGCPPKTCSQDEFR | 101 | P01130 |